About united health products inc - UEEC
United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. It also offers HemoStyp to control bleeding. The company was founded on February 28, 1997 and is headquartered in Mount Laurel, NJ.
UEEC At a Glance
United Health Products, Inc.
520 Fellowship Road
Mount Laurel, New Jersey 08054
| Phone | 1-475-755-1005 | Revenue | 0.00 | |
| Industry | Medical Specialties | Net Income | -2,001,733.00 | |
| Sector | Health Technology | Employees | 10 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
UEEC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -7.047 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.078 |
UEEC Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -200,173.30 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
UEEC Liquidity
| Current Ratio | 0.117 |
| Quick Ratio | 0.117 |
| Cash Ratio | 0.103 |
UEEC Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -721.837 |
| Return on Equity | N/A |
| Return on Total Capital | 149.624 |
| Return on Invested Capital | N/A |
UEEC Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -82.67 |
| Total Debt to Total Assets | 409.657 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | -80.178 |
United Health Products Inc in the News
Aflac CEO says company adapted to health care in a 'post-COVID world'
The insurance industry has made some changes in the wake of COVID-19, and as patients needs evolve with time and medical recommendations, Aflac CEO Dan Amos said.